ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Biotech Investing
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter Biotech Investing
Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting Biotech Investing
Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis Pharmaceutical Investing
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results Pharmaceutical Investing
Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results Biotech Investing
Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update Biotech Investing
Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady Biotech Investing
Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness